Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study of PEG-Paclitaxel In Patients With Advanced Solid Tumors and Lymphomas

NCT00023166 is registered in ClinicalTrials.gov with Enzon Pharmaceuticals, Inc. as lead sponsor.

NCT NCT00023166
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00023166 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study of PEG-Paclitaxel In Patients With Advanced Solid Tumors and Lymphomas
Lead sponsor
Enzon Pharmaceuticals, Inc.
Phase
Phase 1
Overall status
Terminated
Start date
May 31, 2001
Completion date
May 31, 2002
Enrollment
Not reported
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

lymphomas, neoplasm, neoplasm metastasis